- Home
- BDRX vs VRPX Comparison
BDRX vs VRPX Comparison
Compare BDRX & VRPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- VRPX
- Stock Information
- Founded
- BDRX 2000
- VRPX 2016
- Country
- BDRX United Kingdom
- VRPX United States
- Employees
- BDRX N/A
- VRPX N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- VRPX Medicinal Chemicals and Botanical Products
- Sector
- BDRX Health Care
- VRPX Health Care
- Exchange
- BDRX Nasdaq
- VRPX Nasdaq
- Market Cap
- BDRX 3.4M
- VRPX 3.7M
- IPO Year
- BDRX N/A
- VRPX 2021
- Fundamental
- Price
- BDRX $3.80
- VRPX $0.62
- Analyst Decision
- BDRX Strong Buy
- VRPX Hold
- Analyst Count
- BDRX 1
- VRPX 1
- Target Price
- BDRX $200.00
- VRPX N/A
- AVG Volume (30 Days)
- BDRX 55.5K
- VRPX 108.5K
- Earning Date
- BDRX 11-26-2024
- VRPX 11-26-2024
- Dividend Yield
- BDRX N/A
- VRPX N/A
- EPS Growth
- BDRX N/A
- VRPX N/A
- EPS
- BDRX N/A
- VRPX N/A
- Revenue
- BDRX $104,895.00
- VRPX N/A
- Revenue This Year
- BDRX N/A
- VRPX N/A
- Revenue Next Year
- BDRX N/A
- VRPX N/A
- P/E Ratio
- BDRX N/A
- VRPX N/A
- Revenue Growth
- BDRX N/A
- VRPX N/A
- 52 Week Low
- BDRX $3.51
- VRPX $0.36
- 52 Week High
- BDRX $220.25
- VRPX $7.60
- Technical
- Relative Strength Index (RSI)
- BDRX 29.07
- VRPX 43.76
- Support Level
- BDRX $4.70
- VRPX $0.55
- Resistance Level
- BDRX $5.58
- VRPX $0.79
- Average True Range (ATR)
- BDRX 0.48
- VRPX 0.07
- MACD
- BDRX -0.08
- VRPX -0.01
- Stochastic Oscillator
- BDRX 9.03
- VRPX 27.96
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
About VRPX Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.